Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Meningioma: an update.

Eriks Lusis1, David H Gutmann

  • 1Department of Neurology, Washington University School of Medicine, St Louis, Missouri 63110, USA.

Current Opinion in Neurology
|November 16, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Nested pediatric low-grade glioma cerebral organoid avatars reveal glutamatergic neuron stromal growth dependency.

Genes & development·2026
Same author

Differences in Optic Pathway Glioma Prevalence Among Children with Neurofibromatosis Type 1.

The Journal of pediatrics·2026
Same author

Central Precocious Puberty and Optic Pathway Glioma in Children with Neurofibromatosis 1: Associations with Tumor Location, Vision, and Treatment.

The Journal of pediatrics·2026
Same author

Nested ecosystems theory for conceptualizing brain tumors.

Disease models & mechanisms·2026
Same author

Time trends in the male to female ratio for autism incidence: population based, prospectively collected, birth cohort study.

BMJ (Clinical research ed.)·2026
Same author

Head-to-head preclinical treatment design prioritizes promising therapies for neurofibromatosis type 1 optic glioma clinical translation.

Neuro-oncology advances·2026
Same journal

Movement disorders and Parkinson's disease: collaborative and interdisciplinary research to advance understanding of neural circuit dysfunction, pathophysiology, and care: new horizons in technology, neuroimaging, neurophysiology, and genetics toward personalized medicine.

Current opinion in neurology·2026
Same journal

Editorial introduction.

Current opinion in neurology·2026
Same journal

Multimodal mapping of balance dysfunction in Parkinson's disease: a consensus roadmap for research and intervention.

Current opinion in neurology·2026
Same journal

Tourette syndrome: brain neurophysiology, circuit dysfunction, and neuromodulation across invasive and noninvasive approaches.

Current opinion in neurology·2026
Same journal

Dystonia: from phenotypes to genetics and therapeutic advances.

Current opinion in neurology·2026
Same journal

What can we learn from eye movements in movement disorders and Parkinson's disease?

Current opinion in neurology·2026
See all related articles

Recent research illuminates meningioma biology, identifying biomarkers and genetic factors for predicting tumor behavior. These insights pave the way for targeted therapies and improved outcomes for aggressive meningiomas.

Area of Science:

  • Neuro-oncology
  • Molecular biology
  • Genetics

Background:

  • Meningiomas are common CNS neoplasms, often understudied despite their prevalence.
  • Current diagnostic tools are improving, yet meningiomas remain underreported.
  • Effective chemotherapy for meningiomas is lacking, highlighting a critical treatment gap.

Purpose of the Study:

  • To review recent clinical and molecular research on meningioma biology.
  • To discuss the significance of these advances for future research and treatment strategies.
  • To provide insights into meningioma formation, progression, and potential therapeutic targets.

Main Methods:

  • Review of recent clinical and molecular research findings on meningiomas.
  • Analysis of genetic and molecular alterations associated with meningioma.

Related Experiment Videos

  • Evaluation of biomarkers for predicting tumor recurrence and progression.

    • Main Results:

    • Biomarkers like progesterone receptor and COX-2 may predict meningioma recurrence.
    • Genetic alterations including chromosome losses and telomerase activation are linked to aggressive meningiomas.
    • Candidate genes such as NF2 and p53 are implicated in meningioma development and progression.

    Conclusions:

    • Molecular insights offer new research avenues into meningioma formation and malignant progression.
    • Advances in understanding meningioma genetics can improve clinical outcome prediction.
    • Targeted therapies based on molecular findings hold promise for treating aggressive meningiomas.